X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -47.01% |
| Q3 2025 | 1451.73% |
| Q2 2025 | -84.03% |
| Q1 2025 | 1.50% |
| Q4 2024 | -62.89% |
| Q3 2024 | -36.57% |
| Q2 2024 | 8932.93% |
| Q1 2024 | -97.98% |
| Q4 2023 | -25.08% |
| Q3 2023 | -14.27% |
| Q2 2023 | 13.05% |
| Q1 2023 | -51.83% |
| Q4 2022 | -2.43% |
| Q3 2022 | -11.25% |
| Q2 2022 | -47.78% |
| Q1 2022 | -38.43% |
| Q4 2021 | 2.27% |
| Q3 2021 | -23.25% |
| Q2 2021 | -34.74% |
| Q1 2021 | 42.81% |
| Q4 2020 | -19.21% |
| Q3 2020 | -14.70% |
| Q2 2020 | -11.79% |
| Q1 2020 | -24.37% |
| Q4 2019 | 44.46% |
| Q3 2019 | -25.56% |
| Q2 2019 | 68.66% |
| Q1 2019 | -91.38% |
| Q4 2018 | -24.06% |
| Q3 2018 | -28.77% |
| Q2 2018 | -20.22% |
| Q1 2018 | -21.31% |
| Q4 2017 | 406.09% |
| Q3 2017 | -35.94% |
| Q2 2017 | 182.28% |
| Q1 2017 | 61.09% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |